2,600 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by Kercheville Advisors LLC

Kercheville Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,600 shares of the exchange traded fund’s stock, valued at approximately $216,000. Several other hedge […]

Related Keywords

United States ,American , ,Company Profile ,Investment Counselors ,Nasdaq ,National Association Of Securities Dealers Automated Quotation ,York Stock Exchange ,Compass Wealth Management ,Wealth Management ,Kercheville Advisors ,National Market ,New York Stock Exchange ,Fortis Capital Advisors ,Exchange Commission ,J Arnold Wealth Management Co ,American Stock Exchange ,Free Report ,Capital Advisors ,National Association ,Securities Dealers Automated Quotation ,Spdr Sp Biotech Etf ,Nysearca Xbi ,Xbi ,Nysearca ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,